Medi Assist Healthcare Services Limited ("Medi Assist") announced an investment from Massachusetts Institute of Technology (MIT) and 238 Plan Associates LLC (an affiliate of MIT). The aggregate investment of INR 198 crores was secured through a preferential allotment on a private placement basis.
Under the preferential allotment, Medi Assist has issued 37,01,000 fully paid-up equity shares with a face value of ₹5/- each, at an issue price of ₹535 per share, for a total consideration of ₹198 crores. The issue of shares under preferential allotment received unanimous approval from the Board of Medi Assist at their meeting held on August 7, 2025, and was strongly supported by shareholders in an Extra-ordinary General Meeting (EGM) held on September 4, 2025, with an overwhelming 99.15% of votes cast in favor of the transaction.
This capital infusion closely follows acquisition of Fairfax-owned Paramount Health Services & Insurance TPA Private Limited in July 2025 by Medi Assist Insurance TPA, a wholly-owned subsidiary of Medi Assist and Medi Assist’s strategic collaboration for technology solutions in June 2025 with Star Health Insurance and Allied Services, India’s leading private and retail segment health insurer. With this successful capital raise, the company further solidifies its commitment to maintaining a robust capital structure, thereby fueling innovation-led growth.
Satish V N Gidugu, Chief Executive Officer, Medi Assist, stated, "This investment from MIT unequivocally reaffirms Medi Assist’s mission to spearhead India’s digital health transformation. Technology remains at the core of our operations, enabling us to make healthcare simpler, faster, and more transparent. We are steadfast in our commitment to accelerate innovation in AI-led health benefit solutions that improve member experience and payer outcomes elevating healthcare access to an unprecedented level for millions of people.
𝐒𝐭𝐚𝐲 𝐢𝐧𝐟𝐨𝐫𝐦𝐞𝐝 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐮𝐩𝐝𝐚𝐭𝐞𝐬 𝐛𝐲 𝐣𝐨𝐢𝐧𝐢𝐧𝐠 𝐭𝐡𝐞 WhatsApp Channel now! 👈📲
𝑭𝒐𝒍𝒍𝒐𝒘 𝑶𝒖𝒓 𝑺𝒐𝒄𝒊𝒂𝒍 𝑴𝒆𝒅𝒊𝒂 𝑷𝒂𝒈𝒆𝐬 👉 Facebook, LinkedIn, Twitter, Instagram
